Zymar - Gatifloxacin ophthalmic solution, 0.3% - Allergan - Fluoroquinolone approved for bacterial conjunctivitis

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2003年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 47 条
  • [21] Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial
    Baiza-Duran, Leopoldo
    Olvera-Montano, Oscar
    Mercado-Sesma, Arieh R.
    Oregon-Miranda, Aldo A.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (03) : 250 - 255
  • [22] CLINICAL-EVALUATION OF CIPROFLOXACIN OPHTHALMIC SOLUTION 0.3-PERCENT IN YOUNG-CHILDREN WITH ACUTE BACTERIAL CONJUNCTIVITIS
    GROSS, RD
    HOFFMAN, RO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1670 - 1670
  • [23] Azithromycin 1.5 % ophthalmic solution: A guide to its use in purulent bacterial conjunctivitis and trachomatous conjunctivitis
    Keating G.M.
    Lyseng-Williamson K.A.
    Garnock-Jones K.P.
    Drugs & Therapy Perspectives, 2013, 29 (4) : 97 - 101
  • [24] Penetration of gatifloxacin ophthalmic solution 0.3% into human aqueous humor of patients undergoing cataract surgery
    Price, FW
    Price, MO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U546 - U546
  • [25] Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients
    Kim, DH
    Stark, WJ
    O'Brien, TP
    Dick, JD
    OPHTHALMOLOGY, 2005, 112 (11) : 1992 - 1996
  • [26] The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy
    Williams, K. Keven
    McCartney, Mitchell D.
    Rice, Rebecca L.
    Wax, Martin B.
    Hiddemen, Joseph W.
    VETERINARY OPHTHALMOLOGY, 2008, 11 (05) : 327 - 334
  • [27] The effects of topical moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution on corneal healing after bilateral photorefractive keratectomy
    Yee, Richard W.
    Setabutr, Pete
    O Foltermann, Miles
    Sami, Mirwat S.
    Chuang, Alice Z.
    CORNEA, 2006, 25 (09) : S8 - S11
  • [28] Corneal wound healing in New Zealand white rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%
    Williams, K. Keven
    Shepard, Allan R.
    Rice, Rebecca L.
    McCartney, Mitchell D.
    Wax, Martin B.
    Hiddemen, Joseph W.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (06) : 517 - 525
  • [29] A. comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK
    Durrie, DS
    Trattler, W
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2005, 21 (03) : 236 - 241
  • [30] Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% Compared with Moxifloxacin Ophthalmic Solution 0.5% for Treating Bacterial Conjunctivitis
    McDonald, Marguerite B.
    Protzko, Eugene E.
    Brunner, Lynne S.
    Morris, Timothy W.
    Haas, Wolfgang
    Paterno, Michael R.
    Comstock, Timothy L.
    Usner, Date W.
    OPHTHALMOLOGY, 2009, 116 (09) : 1615 - 1623
12345